Wegovy
PulseAugur coverage of Wegovy — every cluster mentioning Wegovy across labs, papers, and developer communities, ranked by signal.
9 day(s) with sentiment data
-
Medicare to offer weight-loss drugs, straining doctor capacity
Starting next month, Medicare will offer weight-loss drugs like Wegovy and Zepbound for a subsidized price of $50 per month. This initiative is expected to lead to a significant surge in demand, potentially overwhelming…
-
GLP-1 Drugs Could Save Adults Hundreds of Thousands in Medical Costs
A new study from the National Bureau of Economic Research (NBER) suggests that middle-aged adults using GLP-1 drugs for obesity could save over $192,000 in lifetime medical costs. These savings are even higher for indiv…
-
Novo Nordisk hit by cyberattack stealing clinical trial data
Novo Nordisk has reported a cyberattack where hackers stole clinical trial data. The company is investigating the incident, which occurred around the same time the UK approved Wegovy for weight management. This attack h…
-
Health plans balk at paying for GLP-1 weight loss drugs
Health plans and employers are increasingly hesitant to cover GLP-1 drugs for weight loss due to high costs and patient discontinuation rates. A new report indicates that nearly half of employers not currently covering …
-
Eli Lilly launches direct-to-consumer drug sales bypassing PBMs
Eli Lilly has launched LillyDirect, a direct-to-consumer platform for its weight-loss medications like Zepbound, bypassing traditional pharmacy benefit managers (PBMs). This integrated system includes online physician r…
-
Novo Nordisk CEO eyes longevity and aesthetics beyond weight loss drugs
Novo Nordisk's CEO, Mike Doustdar, is exploring new therapeutic areas beyond weight loss and diabetes, including longevity and aesthetic medicine. The company is investigating semaglutide's potential to protect vital or…
-
Government healthcare cost projections struggle with GLP-1 drug spending
Government healthcare cost projections for GLP-1 medications like Ozempic and Mounjaro are proving difficult to accurately forecast. Agencies like CMS and CBO rely on historical data and assumptions that may not account…
-
Peptide gray market increasingly uses crypto for transactions
A growing gray market for peptides, used for wellness and the "looksmaxxing" trend, is increasingly relying on cryptocurrency for transactions. Vendors in this space face challenges with traditional payment processors d…
-
Withings launches $280 smart scale for GLP-1 users
Withings has released the BodyFit, a new smart scale priced at $280, specifically designed for users of GLP-1 weight loss medications. This scale aims to help users monitor muscle mass loss, a common side effect of thes…
-
France to reimburse anti-obesity drugs for first time in EU
France is set to become the first European Union country to reimburse anti-obesity medications for severely obese patients starting mid-June. The government estimates this initiative will cost approximately €100 million…
-
GLP-1 drugs show anti-inflammatory benefits beyond weight loss
GLP-1 medications like Ozempic and Wegovy, known for weight loss, are showing promise in treating inflammation and tissue damage, particularly in osteoarthritis. A study in Cell Metabolism found semaglutide reduced infl…
-
GLP-1 drugs may reduce cancer progression, new study suggests
New research presented at the American Society of Clinical Oncology meeting suggests that GLP-1 medications, commonly used for diabetes and weight loss, may also reduce the progression of certain cancers. A study analyz…
-
GLP-1 drug costs surge, pushing up employee healthcare expenses
The cost of GLP-1 weight loss drugs like Ozempic and Wegovy is significantly increasing healthcare expenses for both employers and employees. A recent Milliman Medical Index report indicates a 7.2% rise in annual family…
-
Browser automation platforms Simplex and Finic launch open-source tools
Simplex and Finic are two new platforms designed to automate browser-based tasks for developers. Simplex focuses on streamlining the prior authorization process for healthcare providers by integrating with existing clin…